TAG:
cap
Innovative AP Reports Created by Path Group
By Robert Michel | From the Volume XII No. 12 – August 22, 2005 Issue
CEO SUMMARY: Too often local pathology groups fail to react to intensified sales competition for the biopsy referrals of clinicians in their community. In Torrance, California, the 30 pathologists of Pathology, Inc. decided it was time to invest capital and resources into developing their…
Proteomic Tests Poised For Clinical Market
By Robert Michel | From the Volume XII No. 12 – August 22, 2005 Issue
CEO SUMMARY: Proteomics-based technology is developing rapidly. The strategic collaboration announced last month between Ciphergen Biosystems and Quest Diagnostics Incorporated is potentially worth $25 million. It is an expensive bet that next-generation proteomics tests soon to enter the…
For Quest and LabCorp, The Story is “Molecular”
By Robert Michel | From the Volume XII No. 11 – August 1, 2005 Issue
CEO SUMMARY: Wall Street likes the potential of molecular diagnostics to infuse new revenues and operating profits into the laboratory industry. That is one reason Quest Diagnostics Incorporated and Laboratory Corporation of America are assertively seeking exclusive access to new molecula…
Technology Can Now Enable “Card Swipe” for Draw Sites
By Robert Michel | From the Volume XII No. 11 – August 1, 2005 Issue
COLLECTING SMALL AMOUNTS of money from patients for deductible, co-pay, and self-pay fees has always bedeviled laboratories. However, new technology holds the promise of solving this long-standing problem. BlueCross BlueShield of South Carolina (BCBC-SC) is currently offering a new …
Pinkus DermPath Earns ISO-9000 Certification
By Robert Michel | From the Volume XII No. 11 – August 1, 2005 Issue
CEO SUMMARY: After learning about quality management systems at a recent Executive War College, the lab director at Pinkus Dermatopathology recognized how such techniques could be used in his lab to improve quality, reduce errors, and create a better working environment for both pathologi…
Molecular Diagnostics: How Beaumont Built A Successful Program
By Robert Michel | From the Volume XII No. 11 – August 1, 2005 Issue
CEO SUMMARY: It was about 15 years ago when William Beaumont Hospital and Beaumont Reference Laboratories first began offering molecular diagnostic testing services to clinicians. This successful effort came about because of effective strategic planning, use of consulting expertise at key…
Payer Consolidation: United Buys Pacificare
By Robert Michel | From the Volume XII No. 10 – July 11, 2005 Issue
CEO SUMMARY: For the second time in nine months, a health insurer company has spent around $9 billion to grow by acquisition. This time, it is UnitedHealth Group purchasing PacifiCare Health Systems. These types of deals impact local labs and pathology groups as existing contracts expire….
Consumer-Directed Healthcare by Mango
By Robert Michel | From the Volume XII No. 10 – July 11, 2005 Issue
CEO SUMMARY: This former laboratory executive declares that Consumer-Driven Healthcare Plans (CDHPs) are “the most significant development in health insurance since the widespread introduction of HMOs in the 1980s.” Paul Mango, now at McKinsey & Co., has plenty of good news for la…
Amazing New IT Products Arriving in Healthcare Market
By Robert Michel | From the Volume XII No. 10 – July 11, 2005 Issue
TECHNOLOGY INNOVATIONS are triggering a flow of remarkable new information technology (IT) products into the healthcare marketplace. Not all of these products will gain a foothold, but some have the potential to trigger radical changes in how information flows between patient, provider, and payer. H…
DOJ Sends Subpoenas To Quest & LabCorp
By Robert Michel | From the Volume XII No. 9 – June 20, 2005 Issue
CEO SUMMARY: In Newark, New Jersey, the Office of the U.S. Attorney served subpoenas to each of the two blood brothers, seeking information on “capitation and risk-sharing arrangements with government and private payers for the years 1993 through 1999.” At this point, little is known …
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized